Dr. Yun Wu, MD, PhD

Dr. Wu practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Wu's NPI, 1700982543, was assigned on September 16, 2006. Dr. Wu graduated from Shanghai Medical University in 1991. Dr. Wu holds Texas license L6220.

Dr. Wu's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Wu's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wu practices. Vendor and product names are available with a free account.

Anatomic pathology and clinical pathology is Dr. Wu's primary specialty in the NPI Registry, under taxonomy code 207ZP0102X. Dr. Wu is board certified in anatomic pathology & clinical pathology by the American Board of Pathology. Dmand AI has Dr. Wu's licenses on file in 2 states: Texas and New York.

CMS data shows 722 Medicare services from Dr. Wu across 9 procedure codes in 2024, for 230 Medicare patients. Medicare paid $27,864 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 230 Medicare patients who saw Dr. Wu in 2024. The largest group is 65 to 74, with 140 patients. 75% of them have cancer, and 74% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.36, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wu's median patient age at 54, with 99% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Wu for performance year 2024, reported as part of a group. Dr. Wu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 153 papers to Dr. Wu, published from 2008 to 2025. 2018 was the busiest year, with 12. The most frequent topics are Breast Neoplasms, Cell Line, Tumor and Biomarkers, Tumor. Dr. Wu has published most often in Cancer Res. Dr. Wu's most frequent co-authors are Constance T. Albarracin, MD, PhD, Lei Huo, MD and Hui Chen, MD, PhD.

CMS Open Payments shows 3 general payments to Dr. Wu from 1 drug or device company from 2019 to 2024. Speaker and faculty fees make up the largest share, 97% of the total. Merck Sharp & Dohme Corporation paid the most, $9,400.

Dr. Wu graduated from Shanghai Medical University in 1991.

Dr. Wu is in network with 4 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.